Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor.
J Immunother Cancer. 2021 Apr;9(4):e002371. doi: 10.1136/jitc-2021-002371.
J Immunother Cancer. 2021.
PMID: 33837055
Free PMC article.
Clinical Trial.